Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.35
↑ 64% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-0.99
Historical baseline
PeriodValueYoY Change
2025-0.35-43.8%
2024-0.25+69.0%
2023-0.79-108.6%
2022-0.38+75.0%
2021-1.52+44.4%
2020-2.73-122.8%
2019-1.23-253.4%
2018-0.35+75.5%
2017-1.42-64.5%
2016-0.86-